National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Dietary Supplements: A Framework for Evaluating Safety (2005)
Institute of Medicine (IOM)

Citation Manager

. "1 Introduction and Background." Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
41
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Supplements: A Framework for Evaluating Safety

FDA. 2004. Medical Product Safety Information. MedWatch Safety Information. Available at http://www.fda.gov/medwatch/safety.htm. Accessed March 14, 2004.

Ford ES. 2001. Vitamin supplement use and diabetes mellitus incidence among adults in the United States. Am J Epidemiol 153:892–897.


Hartz SC, Otradovec CL, McGandy RB, Russell RM, Jacob RA, Sahyoun N, Peters H, Abrams D, Scura LA, Whinston-Perry RA. 1988. Nutrient supplement use by healthy elderly. J Am Coll Nutr 7:119–128.

Hunt JR. 1996. Position of the American Dietetic Association: Vitamin and mineral supplementation. J Am Diet Assoc 96:73–77.

Hunt JR, Dwyer J. 2001. Position of the American Dietetic Association: Food fortification and dietary supplements. J Am Diet Assoc 101:115–132.

Hutt PB, Merrill RA. 1991. Regulation of vitamin-mineral supplements. In: Food and Drug Law. Cases and Materials. 2nd ed. Westbury, NY: The Foundation Press. Pp. 204–228.


Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. 2002. Recent patterns of medication use in the ambulatory adult population of the United States. The Sloan Survey. J Am Med Assoc 287:337–344.

Khatcheressian LAW. 1999. Regulation of dietary supplements: Five years of DSHEA. Food Drug Law J 54:623–644.

Kim I, Williamson DF, Byers T, Koplan JP. 1993. Vitamin and mineral supplement use and mortality in a U.S. cohort. Am J Public Health 83:546–550.

Koplan JP, Annest JL, Layde PM, Rubin GL. 1986. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health 76:287–289.

Kraak V, Pelletier DL, Dohhahite J. 2002. Food, health, and nutrient supplements: Beliefs among food stamp-eligible women and implications for food stamp policy. Fam Econ Nutr Rev 14:21–35.


Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Greger JL. 1998. Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr 128:2355–2362.


McNamara SH. 1995. Dietary supplements of botanicals and other substances: A new era of regulation. Food Drug Law J 50:341–348.

Millikan LE. 1999. Anecdotal therapies. Adv Exp Med Biol 455:407–411.


Nayga RM, Reed DB. 1999. Factors associated with the intake of dietary supplements. Fam Econ Nutr Rev 12:43–48.

NBJ’s Annual Industry Overview VIII. 2003. Nutr Bus J 8:1–9.

Nesheim MC. 1999. What is the research base for the use of dietary supplements? Public Health Nutr 2:35–38.

Neuhouser ML, Patterson RE, Levy L. 1999. Motivations for using vitamin and mineral supplements. J Am Diet Assoc 101:1340–1346.

Newman V, Rock CL, Faerber S, Flatt SW, Wright FA, Pierce JP. 1998. Dietary supplement use by women at risk for breast cancer recurrence. J Am Diet Assoc 98:285–292.


OIG (Office of Inspector General). 2001. Adverse Event Reporting for Dietary Supplements. An Inadequate Safety Valve. OEI-01-00-00180. Boston, MA: OIG, Department of Health and Human Services.


Pelletier DL, Kendall A. 1997. Supplement use may not be associated with better food intake in all population groups. Fam Econ Nutr Rev 10:32–44.

Pendergast WR. 1997. Dietary supplements. In: Brady RP, Cooper RM, Silverman RS, eds. Fundamentals of Law and Regulation. An In-Depth Look at Foods, Veterinary Medicines, and Cosmetics. Washington, DC: Food and Drug Law Institute. Pp. 257–283.

Pezzuto JM, Compadre CM, Swanson SM, Nanayakkara NPD, Kinghorn AD. 1985. Metabolically activated steviol, the aglycone of stevioside, is mutagenic. Proc Natl Acad Sci 82:2478–2482.

Page
41
Front Matter (R1-R20)
Executive Summary (1-18)
1 Introduction and Background (19-42)
2 Approaches Used by Others and Existing Safety Frameworks (43-84)
3 The Framework (85-125)
4 Categories of Scientific Evidence--Human Information and Data (126-155)
5 Categories of Scientific Evidence--Animal Data (156-174)
6 Categories of Scientific Evidence--Information About Related Substances (175-216)
7 Categories of Scientific Evidence--In Vitro Data (217-234)
8 Interactions (235-246)
9 Vulnerable Groups and Prevalance of Use (247-252)
10 Scientific Principles for Integrating and Evaluating the Available Data (253-268)
11 Applying the Framework: Case Studies Using the Prototype Safety Monographs (269-291)
12 Factors Influencing Use of the Safety Framework (292-296)
13 Findings and Recommendations (297-306)
Appendix A: Existing Frameworks or Systems for Evaluating the Safety of Other Substances (307-315)
Appendix B: Scope of Work and Comments to Initial July 2002 Framework (316-321)
Appendix C: Plant Family Information (322-355)
Appendix D: Chaparral: Prototype Monograph Summary (356-362)
Appendix E: Glucosamine: Prototype Monograph Summary (363-366)
Appendix F: Melatonin: Prototype Monograph Summary (367-371)
Appendix G: Chromium Picolinate: Prototype Monograph Summary (372-375)
Appendix H: Saw Palmetto: Prototype Monograph Summary (376-379)
Appendix I: Shark Cartilage: Prototype Monograph Summary (380-384)
Appendix J: Prototype Focused Monograph: Review of Liver-Related Risks for Chaparral (385-449)
Appendix K: Protoype Focused Monograph: Review of Anti-Androgenic Risks of Saw Palmetto Ingestion by Women (450-477)
Appendix L: Acknowledgements (478-480)
Appendix M: Biographical Sketches of Commitee Members (481-488)
Index (489-506)